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Alzheimer's disease (AD) is a complex neurodegenerative disease that is manifested by 
the gradual loss of short-term and, at more advanced stages, also of long-term memory. The 
characteristic histopathological features of AD is the presence of neuritic plaques and 
neurofibrillary tangles in affected brain regions. Cholinergic neurotransmission is also one of 
the key pathological findings in AD. Only two drug groups are used in AD therapy. The first 
group consists of acetylcholinesterase inhibitors (AChEIs). Memantine, which is a glutamate 
receptors antagonist, belongs to the second one. The aim of the diploma thesis was the synthesis 
of a new group of drugs acting as multipotent ligands (multi-target directed ligands, MTDLs) 
derived from huprines. The new compounds were designed to be able to interact with both 
anionic sites of acetylcholinesterase (AChE), thereby exaggerating the enzyme-inhibiting 
effect. In the experimental part of the diploma thesis two structural types of huprines were 
designed and prepared. The heterodimers based on huprine-L-tryptophan (HupY-L-Trp) with 
different side chain lengths were the first type. The aim of the second synthesis was the design 
and preparation of a 2-methoxyhuprine. The inhibitory activity of the new derivatives against 
cholinesterase (ChE) was determined by method of Ellman and obtained results are expressed 
as the IC50 value. These measurements were carried out by the staff of the Department of 
Toxicology and Military Pharmacy in Hradec Králové (Faculty of Military Health Sciences, 
University of Defense, Brno). The biological results of the new compounds were compared 
with the reference drugs (tacrine, 6-chlorotacrine and 7-methoxytacrine). The rate of 
permeability of new derivatives through the blood-brain barrier was determined by using 
parallel artificial membrane permeability assay (PAMPA). This determination was carried out 
by the staff of the Centre of Biomedical Research (Faculty Hospital Hradec Králové). The 
biological results of the new compounds were compared with the references. All newly emerged 
compounds demonstrated inhibitory activity against both ChE subtypes in micromolar to 
nanomolar IC50 values with presumed CNS availability. 
 
